- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02543385
S Ketamine Use in Total Abdominal Hysterectomy (SKET)
The Use of S Ketamine Versus Placebo During Target Controlled Intravenous Anaesthesia to Reduce Morphine Consumption and Side-Effects After Abdominal Hysterectomy: A Randomized Control Trial
Study Overview
Detailed Description
In recent times it has been suggested that NMDA receptor antagonist like ketamine when used in small doses helps reducing postoperative pain and opioid consumption without compromising wakefulness and or causing its psycho mimetic adverse effect .
The clinical utility of S+ ketamine as an adjuvant intra-operatively remains controversial. The NMDA receptor activation and subsequent biochemical process has been proven to play an important role in both hyperalgesia after tissue injury and the development of opioid tolerance. Various studies have reported the advantage of S+ ketamine over traditional balanced anaesthesia, but may lead to secondary hyperalgesia and increased opioid requirement in post operative period in both animals and healthy human volunteers. Other studies showed that 48 hours continuous administration of small-dose ketamine, together with patient-controlled analgesia (PCA) with morphine, or systemic, epidural co-administration of ketamine and opiates markedly reduced cumulative morphine. However, the dosage, route and timing of administration of S+-ketamine varied in different setting.
Study Type
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Females above the age of 21 years old scheduled undergoing open abdominal hysterectomy with remifentanil-propofol TCI in KKH for benign condition (fibroids, adenomyosis),
- Be willing and able to give written informed consent for participation in this study
- ASA I/II patient's.
Exclusion Criteria:
- Patient with contraindications to the use of S+ketamine, as listed in the product label e.g. untreated or insufficiently treated thyroid hyperfunction, unstable angina pectoris or myocardial infarction within the last 6 months, diseases of the CNS, increased intraocular pressure and perforating ocular injuries, surgical procedures in the upper respiratory tract, etc
- Patients with a h/o drug or alcohol abuse
- Regular use of analgesics, or use of opioids within 12 hours of surgery
- Patient on chronic use of benzodiazepine or neurololeptics
- Patient on thyroid replacement hormone
- H/o IHD,HTN,Thyroid disorder.
- BMI> 30kg/m2.
- H/o Psychiatric disorder.
- Laproscopic surgery converted to open surgery.
- Pregnant or breast feeding female's.
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: SKET
Intravenous S+ketamine 0.25 mg/kg (i.v.
bolus) at the beginning and 0.25 mg/kg (i.v.
bolus) 20 minutes before extubation along with remifentanil according to Minto model and propofol infusion according to Schnider model through target control infusion pump.
|
S+ketamine will be given in group I only in the doses of 0.25mg/kg (iv bolus) before induction along with midazolam and 0. 25 mg/kg (iv bolus) 20 minutes prior to extubation
|
Placebo Comparator: PLACEBO
Intravenous normal saline (as placebo, with similar volume) at the beginning and 20 minutes before extubation along with remifentanil according to Minto model and propofol according to Schnider model through target control infusion pump.
|
S+ketamine will be given in group I only in the doses of 0.25mg/kg (iv bolus) before induction along with midazolam and 0. 25 mg/kg (iv bolus) 20 minutes prior to extubation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
S ketamine used in TAH
Time Frame: 1 YEAR
|
1 YEAR
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Dissociative
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Excitatory Amino Acid Antagonists
- Excitatory Amino Acid Agents
- Psychotropic Drugs
- Antidepressive Agents
- Ketamine
- Esketamine
Other Study ID Numbers
- 2008/905/D
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Total Abdominal Hysterectomy
-
Zeynep Kamil Maternity and Pediatric Research and...UnknownTOTAL ABDOMINAL HYSTERECTOMYTurkey
-
Southern HealthGyrus ACMIUnknownTotal Abdominal HysterectomyAustralia
-
University of OttawaCompletedElective Total or Subtotal Abdominal HysterectomyCanada
-
Mansoura UniversityRecruitingTotal Laparoscopic HysterectomyEgypt
-
Ilsan Cha hospitalRecruitingTotal Laparoscopic HysterectomyKorea, Republic of
-
ZSX Medical LLCCompletedTotal Laparoscopic HysterectomyMexico
-
Ain Shams Maternity HospitalRecruitingTotal Laparoscopic HysterectomyEgypt
-
Istanbul UniversityUniversity of SurreyCompletedTotal Laparoscopic Hysterectomy | Benign ConditionsTurkey
-
Yonsei UniversityCompletedPatients Undergoing Total Laparoscopic HysterectomyKorea, Republic of
-
Kocaeli UniversityCompletedAbdominal HysterectomyTurkey
Clinical Trials on S Ketamine
-
Eye & ENT Hospital of Fudan UniversityCompletedPain, Procedural | Emotions | Separation AnxietyChina
-
Turku University HospitalUniversity of Turku; University of HelsinkiCompletedPain, PostoperativeFinland
-
Medical University of ViennaUnknownDepression | KetamineAustria
-
Medical University of ViennaRecruiting
-
Erasmus Medical CenterEnrolling by invitationComplex Regional Pain Syndromes | CRPS (Complex Regional Pain Syndromes)Netherlands
-
Peking University First HospitalPeking University International Hospital; Women's Hospital School Of Medicine... and other collaboratorsCompletedPostpartum Depression | Ketamine | Prenatal DepressionChina
-
Peking University First HospitalPeking University International Hospital; Women's Hospital School Of Medicine... and other collaboratorsCompletedPostpartum Depression | Ketamine | Prenatal DepressionChina
-
Janssen Research & Development, LLCCompleted
-
The Second Hospital of Anhui Medical UniversityRecruiting
-
Tianjin Medical University General HospitalRecruitingPostoperative Pain | Postoperative Cognitive DysfunctionChina